Scancell Holdings Share Price | |
---|---|
Price | 9.60 |
Bid | 9.40 |
Ask | 9.80 |
Change | 0.00 (0.00%) |
Volume | 148,854 |
Open | 9.36 |
High | 9.60 |
Low | 9.36 |
Prev. Close | 9.60 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 928.98m |
Market Capitalisation | £89.18m |
Market Size | 30,000 |
52 Week High | 17.375 |
52 Week High Date | 20-Sep-2023 |
52 Week Low | 7.65 |
52 Week Low Date | 05-Sep-2023 |
# Trades | 8 |
---|---|
Vol. Sold | 148,854 |
Sold Value | £14.08k |
Vol. Bought | 0 |
Bought Value | £N/A |
PE Ratio | -6.402561 |
Earnings | -1.4994 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
26-Apr-24 | 14:45:43 | 9.45 | 124,469 | Sell* | 9.40 | 9.80 | 11.76k | O Ordinary |
26-Apr-24 | 12:56:16 | 9.404 | 1,000 | Sell* | 9.40 | 9.80 | 94.04 | O Ordinary |
26-Apr-24 | 12:48:47 | 9.50 | 750 | Sell* | 9.40 | 9.80 | 71.25 | O Ordinary |
26-Apr-24 | 12:40:34 | 9.50 | 21,000 | Sell* | 9.40 | 9.80 | 1,995 | O Ordinary |
26-Apr-24 | 12:19:43 | 9.50 | 100 | Sell* | 9.40 | 9.80 | 9.50 | O Ordinary |
26-Apr-24 | 09:19:55 | 9.404 | 1,051 | Sell* | 9.40 | 9.80 | 98.84 | O Ordinary |
26-Apr-24 | 08:21:06 | 9.40 | 135 | Sell* | 9.40 | 9.80 | 12.69 | O Ordinary Trade was executed as an SI |
26-Apr-24 | 08:00:21 | 9.36 | 349 | Sell* | 9.40 | 9.80 | 32.67 | UT Uncrossing Trade |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
06-Dec-23 | 05-Dec-23 | Buy | Jean-Michel Cosséry held the position of Non-Executive Chairman at the time of this trade.Jean-Michel Cosséry | 11.00 | GBX | 454,545 | 454,545 |
06-Dec-23 | 05-Dec-23 | Buy | Lindy Durrant held the position of CEO at the time of this trade.Lindy Durrant | 11.00 | GBX | 272,727 | 272,727 |
03-Mar-22 | 02-Mar-22 | Buy | Martin Diggle held the position of Non-Executive Director at the time of this trade.Martin Diggle | 12.00 | GBX | 250,000 | 117,729,029 |
03-Nov-21 | 02-Nov-21 | Buy | Martin Diggle held the position of Non-Executive Director at the time of this trade.Martin Diggle | 19.00 | GBX | 200,000 | 118,479,029 |
02-Nov-21 | 29-Oct-21 | Buy | Martin Diggle held the position of Non-Executive Director at the time of this trade.Martin Diggle | 19.00 | GBX | 100,000 | 118,279,029 |
Scancell is focused on developing innovative immunotherapies for cancer that stimulate the body’s own immune system.